Bilateral subthalamic nucleus stimulation in the treatment of neurodegeneration with brain iron accumulation type 1

Stereotactic and Functional Neurosurgery

Volumn 89, Issue 3, 2011, Pages 162-166

  Ge, Ming ^a   Zhang, Kai ^a   Ma, Yu ^b   Meng, Fan Gang ^b   Hu, Wen Han ^b   Yang, An Chao ^a   Zhang, Jian Guo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Deep brain stimulation; Dystonia; Neurodegeneration with brain iron accumulation; Subthalamic nucleus

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL EFFECTIVENESS; DYSARTHRIA; FOLLOW UP; GENERAL ANESTHESIA; GENERALIZED DYSTONIA; HUMAN; MALE; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION TYPE 1; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RIGIDITY; SUBTHALAMIC NUCLEUS;

ADOLESCENT; DEEP BRAIN STIMULATION; HUMANS; MALE; NEUROAXONAL DYSTROPHIES; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 79953872655     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000323374     Document Type: Article

References (24)

1. Albright AL, Barry MJ, Fasick P, et al: Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery 1996;38:934-938.
2. Tsukamoto H, Inui K, Taniike M, et al: A case of Hallervorden-Spatz disease: progressive and intractable dystonia controlled by bilateral thalamotomy. Brain Dev 1992;14:269-272.
3. Justesen CR, Penn RD, Kroin JS, et al: Stereotactic pallidotomy in a child with Hallervorden-Spatz disease. Case report. J Neurosurg 1999;90:551-554. (Pubitemid 29104607)
4. Kyriagis M, Grattan-Smith P, Scheinberg A, et al: Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. J Paediatr Child Health 2004;40:322-325. (Pubitemid 38829819)
5. Balas I, Kovacs N, Hollody K: Staged bilateral stereotactic pallidothalamotomy for life-threatening dystonia in a child with Hallervorden-Spatz disease. Mov Disord 2006;21:82-85. (Pubitemid 43273756)
6. Isaias IU, Alterman RL, Tagliati M: Deep brain stimulation for primary generalized dystonia: long-term outcomes. Arch Neurol 2009;66:465-470.
7. Mueller J, Skogseid IM, Benecke R, et al: Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord 2008;23:131-134. (Pubitemid 351281232)
8. Vercueil L, Pollak P, Fraix V, et al: Deep brain stimulation in the treatment of severe dystonia. J Neurol 2001;248:695-700. (Pubitemid 32695867)
9. Krause M, Fogel W, Kloss M, Rasche D, Volkmann J, Tronnier V: Pallidal stimulation for dystonia. Neurosurgery 2004;55:1361-1368. (Pubitemid 39612883)
10. Zhang JG, Zhang K, Wang ZC, et al: Deep brain stimulation in the treatment of secondary dystonia. Chin Med J (Engl) 2006;119:2069-2074. (Pubitemid 46017667)
11. Zhang JG, Zhang K, Wang ZC: Deep brain stimulation in the treatment of tardive dystonia. Chin Med J (Engl) 2006;119:789-792. (Pubitemid 43796839)
12. Krause M, Fogel W, Tronnier V, et al: Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 2006;21:2255-2257. (Pubitemid 46140453)
13. Umemura A, Jaggi JL, Dolinskas CA, et al: Pallidal deep brain stimulation for long-standing severe generalized dystonia in Hallervorden-Spatz syndrome. Case report. J Neurosurg 2004;100:706-709. (Pubitemid 38372854)
14. Chacko B, Seshadri P, Sudarsanam TD: Generalised dystonia: clinical diagnosis is possible. Hong Kong Med J 2009;15:224-226.
15. Mikati MA, Yehya A, Darwish H, et al: Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. Eur J Paediatr Neurol 2009;13:61-64.
16. Isaac C, Wright I, Bhattacharyya D, et al: Pallidal stimulation for pantothenate kinase-associated neurodegeneration dystonia. Arch Dis Child 2008;93:239-240. (Pubitemid 352025499)
17. Shields DC, Sharma N, Gale JT, et al: Pallidal stimulation for dystonia in pantothenate kinase-associated neurodegeneration. Pediatr Neurol 2007;37:442-445. (Pubitemid 350087640)
18. Castelnau P, Cif L, Valente EM, et al: Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 2005;57:738-741. (Pubitemid 40628863)
19. Hallervorden J, Spatz H: Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Z Ges Neurol Psychiat 1922;79:254-302.
20. Hayflick SJ: Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr Opin Pediatr 2003;15:572-577.
21. Hayflick SJ, Hartman M, Coryell J, et al: Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol 2006;27:1230-1233. (Pubitemid 44897631)
22. Swaiman KF: Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:102-108.
23. Mink JW: Basal ganglia motor function in relation to Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:112-117.
24. Vitek JL, Chockkan V, Zhang JY, et al: Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999;46:22-35. (Pubitemid 29314379)